Mfn2em2Gwd
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Mfn2em2Gwd |
| Name: |
mitofusin 2; endonuclease-mediated mutation 2, Gerald W Dorn |
| MGI ID: |
MGI:7563989 |
| Synonyms: |
Mfn2T105M |
| Gene: |
Mfn2 Location: Chr4:147958056-147989161 bp, - strand Genetic Position: Chr4, 78.56 cM
|
| Alliance: |
Mfn2em2Gwd page
|
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: CRISPR/Cas9 technology generated a C to T change resulting in a threonine to methionine substitution at amino acid 105 (p.T105M) in exon 6. Two synonymous mutations, p.S106 (AGC to TCA) and p.S110 (AGC to TCG) were introduced to prevent the binding and recutting of the sequence by gRNA. This is a Charcot-Marie-Tooth disease type 2A-associated mutation.
(J:342938)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Mfn2 Mutation: |
27 strains or lines available
|
|
| Original: |
J:342938 Franco A, et al., A human mitofusin 2 mutation can cause mitophagic cardiomyopathy. Elife. 2023 Nov 1;12 |
| All: |
1 reference(s) |
|